Cliff Asness’s Janux Therapeutics JANX Stock Holding History

Cliff Asness’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.66M	Buy	+108,077	New	+$1.57M	﹤0.01%	2728
2025 Q2	–	Sell	-9,717	Closed	-$262K	–	3336
2025 Q1	$262K	Buy	9,717 +4,059	+72%	+$153K	﹤0.01%	2748
2024 Q4	$303K	Buy	5,658 +134	+2%	+$7.09K	﹤0.01%	2484
2024 Q3	$251K	Buy	5,524 +399	+8%	+$17.4K	﹤0.01%	2482
2024 Q2	$215K	Buy	+5,125	New	+$241K	﹤0.01%	2397

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Cliff Asness's JANX Position: Q2 2026 in Review

Cliff Asness opened a new position in Janux Therapeutics (JANX) in Q2 2026: 108,077 shares worth $1.66M. The stake represents ﹤0.01% of the portfolio and ranks #2728 among its holdings. This is a return to the name: Cliff Asness previously reported a position in JANX as recently as Q1 2025.

Cliff Asness first reported a position in JANX in Q2 2024 and has held it in 5 quarters since. 196 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Cliff Asness held 108,077 shares of Janux Therapeutics worth $1.66M as of Q2 2026.
Janux Therapeutics was a new Cliff Asness position in Q2 2026.
Janux Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2728 holding.
Cliff Asness first reported a position in Janux Therapeutics in Q2 2024 and has held it in 5 quarters since.
196 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.